| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0007 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |